| 标题 |
KT-621, an Oral, Once Daily, Targeted STAT6 Degrader: First-in-Human Phase 1a Safety, Pharmacokinetics, Pharmacodynamics and Th2 Biomarker Effects |
| 网址 | |
| DOI |
10.25251/t4cqj323
doi
|
| 其它 |
期刊:Skin 作者:Arsalan Shabbir; Sagar Agarwal; Alice McDonald; Kelvin Shi; Annie L. Conery; et al 出版日期:2025-11-10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)